Status: current, Defined. Date: 31-Mar 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5031000036115 | Viramune XR (nevirapine 400 mg) modified release tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 5041000036113 | Viramune XR 400 mg modified release tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Viramune XR 400 mg modified release tablet | has Australian BoSS | nevirapine | true | Inferred relationship | Some | 1562727510 | |
| Viramune XR 400 mg modified release tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Viramune XR 400 mg modified release tablet | Is a | Viramune XR | true | Inferred relationship | Some | ||
| Viramune XR 400 mg modified release tablet | Is a | nevirapine 400 mg modified release tablet | true | Inferred relationship | Some | ||
| Viramune XR 400 mg modified release tablet | has unit of use | tablet | true | Inferred relationship | Some | 1562727511 | |
| Viramune XR 400 mg modified release tablet | has manufactured dose form | modified release tablet | true | Inferred relationship | Some | ||
| Viramune XR 400 mg modified release tablet | has intended active ingredient | nevirapine | true | Inferred relationship | Some | 1562727510 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Viramune XR 400 mg modified release tablet, 30 | has TPUU | True | Viramune XR 400 mg modified release tablet | Inferred relationship | Some | 1 |
| Viramune XR 400 mg modified release tablet, 30, blister pack | has TPUU | True | Viramune XR 400 mg modified release tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR